share_log

亞盛醫藥-B:(1)採納2022年受限制股份單位計劃;及 (2)根據2022年受限制股份單位計劃首次授出獎勵

ASCENTAGE-B: (1) ADOPTION OF THE 2022 RSU SCHEME; AND (2) INITIAL GRANT OF AWARDS UNDER THE 2022 RSU SCHEME

Jun 23, 2022 10:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more